$UBX Unity Biotechnology, Inc. Pennant formed

NASDAQ:UBX   Unity Biotechnology, Inc
Unity Biotechnology , Inc. operates as a biotechnology company engaged in the research and development of therapeutics to extend the human health span. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi and Daohong Zhou on March 30, 2009 and is headquartered in Brisbane, CA.
18% short interest
Average analysts price target $21.00 | BUY


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.